1. Home
  2. ENOV vs SSII Comparison

ENOV vs SSII Comparison

Compare ENOV & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • SSII
  • Stock Information
  • Founded
  • ENOV 1995
  • SSII N/A
  • Country
  • ENOV United States
  • SSII India
  • Employees
  • ENOV N/A
  • SSII N/A
  • Industry
  • ENOV Fluid Controls
  • SSII
  • Sector
  • ENOV Industrials
  • SSII
  • Exchange
  • ENOV Nasdaq
  • SSII Nasdaq
  • Market Cap
  • ENOV 1.6B
  • SSII 1.3B
  • IPO Year
  • ENOV 2008
  • SSII N/A
  • Fundamental
  • Price
  • ENOV $32.14
  • SSII $7.00
  • Analyst Decision
  • ENOV Strong Buy
  • SSII
  • Analyst Count
  • ENOV 6
  • SSII 0
  • Target Price
  • ENOV $51.00
  • SSII N/A
  • AVG Volume (30 Days)
  • ENOV 1.0M
  • SSII 42.7K
  • Earning Date
  • ENOV 11-05-2025
  • SSII 08-07-2025
  • Dividend Yield
  • ENOV N/A
  • SSII N/A
  • EPS Growth
  • ENOV N/A
  • SSII N/A
  • EPS
  • ENOV N/A
  • SSII N/A
  • Revenue
  • ENOV $2,189,576,000.00
  • SSII $27,623,624.00
  • Revenue This Year
  • ENOV $9.13
  • SSII N/A
  • Revenue Next Year
  • ENOV $6.39
  • SSII N/A
  • P/E Ratio
  • ENOV N/A
  • SSII N/A
  • Revenue Growth
  • ENOV 14.40
  • SSII 134.89
  • 52 Week Low
  • ENOV $25.47
  • SSII $0.32
  • 52 Week High
  • ENOV $49.83
  • SSII $22.42
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 62.91
  • SSII 52.84
  • Support Level
  • ENOV $30.00
  • SSII $6.52
  • Resistance Level
  • ENOV $31.76
  • SSII $7.05
  • Average True Range (ATR)
  • ENOV 1.04
  • SSII 0.64
  • MACD
  • ENOV 0.21
  • SSII -0.01
  • Stochastic Oscillator
  • ENOV 82.68
  • SSII 51.13

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About SSII SS Innovations International Inc.

SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.

Share on Social Networks: